News

Gladstone in the News December 6, 2021

Bay Area Scientists Rush to Study Local Omicron Virus Samples for Health Clues

San Francisco Chronicle—The identification of an individual infected with the Omicron variant of SARS-CoV-2 in San Francisco is helping local scientists assess the danger posed by the virus. Melanie Ott, director of the Gladstone Institute of Virology, explains that experiments using virus samples from that individual could help determine how well the available vaccines hold up to Omicron’s mutations.

Gladstone Experts COVID-19 Virology Ott Lab

Article December 1, 2021

How Close Are We to a Cure for HIV?

Researchers at Gladstone Institutes focus on innovative strategies that could finally allow people living with HIV to stop taking daily medications

Gladstone Experts HIV/AIDS Virology Greene Lab Ott Lab Roan Lab Weinberger Lab Deep Dive

Gladstone in the News November 18, 2021

New Clues to Delta Variant’s Spread in Studies of Virus-Like Particles

NIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.

Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab

Article November 4, 2021

New Method Sheds Light on Why Some SARS-CoV-2 Variants Are More Infectious

Using virus-like particles, researchers find an unexpected explanation for why some coronavirus variants spread faster

Research (Publication) Data Science and Biotechnology Virology Doudna Lab Ott Lab

Video October 22, 2021

Staying Safe over the Holidays

Gladstone virologists discuss the state of the pandemic and how to stay safe this holiday season

COVID-19 Greene Lab Ott Lab

Article August 17, 2021

A New Approach to Curing HIV

Armed with a $26.5-million grant, a multi-institution collaboratory will tackle HIV in a new way

Grants News Release HIV/AIDS Virology Ott Lab CRISPR/Gene Editing

Article May 26, 2021

A Comprehensive Profile of California’s “Homegrown” Coronavirus

New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it

News Release Research (Publication) COVID-19 Virology Ott Lab

Article May 19, 2021

How COVID-19 Is Changing Academic Publishing

While the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quickly

Gladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard Lab

Gladstone in the News April 21, 2021

Women in Medicine Finally Have Spotlight in COVID-19 Fight After Decades of Diversity Building

ABC7 News—Senior Investigator Melanie Ott, PhD, Director of the Gladstone Institute of Virology, talks about the long path to leadership and recognition for women in medicine.

COVID-19 Virology Ott Lab

Gladstone in the News April 8, 2021

At Home, on Your Phone, Results in Minutes: How COVID Has Changed the Future of Health Tests

San Francisco Business Times—Senior Investigator Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni explain how the CRISPR- and smartphone-based diagnostic platform they recently developed with UC Berkeley Dan Fletcher, PhD, and Nobel Laureate Jennifer Doudna, PhD, could allow low-cost and widespread testing and help to quickly curb the course of this and future pandemics.

COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Article March 15, 2021

New Insights into How COVID-19 Causes Heart Damage

Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and create a system that can be used to screen potential therapies

News Release Research (Publication) COVID-19 Cardiovascular Disease Virology Conklin Lab McDevitt Lab Ott Lab

Gladstone in the News March 6, 2021

COVID: A User’s Guide to the Coronavirus Variants Emerging in California and Beyond

The Mercury News—Director of Gladstone Institute of Virology Melanie Ott, MD, PhD, comments on the new coronavirus variants and says vaccines currently distributed in the US protect against hospitalization and death from COVID-19.

Gladstone Experts COVID-19 Virology Ott Lab

Gladstone in the News March 5, 2021

Women Who Lead Influencers: Finding a Way through a Crisis

San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of several key Bay Area women life scientists sharing their views on their careers, the pandemic, and the path ahead for women leaders.

Gladstone Experts COVID-19 Virology Ott Lab

Article February 28, 2021

STAT Madness Is on, and Gladstone Is a Finalist

A Gladstone discovery could be selected as the top innovation in biomedicine

Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene Editing

Gladstone in the News January 20, 2021

The Coronavirus Is Changing Faster Than Scientists Thought. Can Vaccines Still Stamp It Out?

San Francisco Chronicle—New coronavirus variants are emerging around the world, including in the Bay Area. Melanie Ott, director of the Gladstone Institute of Virology, explains that if the vaccine rollout isn’t fast enough, viral variants that can evade the vaccine may become prevalent, rendering the vaccine partially ineffective.

Gladstone Experts COVID-19 Virology Ott Lab